BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice.
Vicente VillanuevaFrancisco Javier López-GonzálezJosé Angel MauriJuan Rodriguez-UrangaMarta Olivé-GadeaJavier MontoyaJesus Ruiz-GiménezJorge Zuritanull nullPublished in: Acta neurologica Scandinavica (2018)
In a large population of patients with predominantly drug-resistant epilepsy, brivaracetam was effective and well-tolerated; no unexpected AEs occurred over 1 year, and the incidence of PAEs was lower compared with levetiracetam.